98-33881. Manufacturer of Controlled Substances; Notice of Application

[Federal Register Volume 63, Number 246 (Wednesday, December 23, 1998)]
[Notices]
[Page 71156]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-33881]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on May 17, 1998, Eli-Elsohly 
Laboratories, Inc., Mahmoud A. Elsohly, PhD, 5 Industrial Park Drive, 
Oxford, Mississippi 38655, made application by renewal to the Drug 
Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                            Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols  (7370)..............................           I
Amphetamine (1100).........................................          II
Methamphetamine (1150).....................................          II
Cocaine (9041).............................................          II
Codeine (9050).............................................          II
Dihydrocodeine (9120)......................................          II
Oxycodone (9143)...........................................          II
Hydromorphone (9150).......................................          II
Benzoylecgonine (9180).....................................          II
Hydrocodone (9193).........................................          II
------------------------------------------------------------------------

    The firm plans to bulk manufacture non-deuterated controlled 
substances for use as analytical standards and deuterated controlled 
substances for use as internal standards.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, United States Department of 
Justice, Washington, D.C. 20537, Attention: DEA Federal Register 
Representative (CCR), and must be filed no later than February 22, 
1999.

    Dated: December 14, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 98-33881 Filed 12-27-98; 8:45 am]
BILLING CODE 4410-09-M